Literature DB >> 18854870

Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4.

Liesbeth Backx1, Berten Ceulemans, Joris Robert Vermeesch, Koen Devriendt, Hilde Van Esch.   

Abstract

The tyrosine kinase receptor ErbB4 (erythroblastic leukemia viral oncogene homolog 4) plays a crucial role in numerous neurobiological processes in the developing and adult brain. Moreover, recent molecular genetics studies implicate ErbB4 in the pathophysiology of schizophrenia. However, the phenotypic consequences of haploinsufficiency of ErbB4 are not known, as no coding mutations have been identified until now. Here, we present a patient with early myoclonic encephalopathy and profound psychomotor delay with a de novo reciprocal translocation t(2;6)(q34;p25.3), disrupting the ErbB4 gene. This patient represents the first case of haploinsufficiency for one of the ErbB family members of tyrosine kinase receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854870      PMCID: PMC2986164          DOI: 10.1038/ejhg.2008.180

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4.

Authors:  J P Golding; P Trainor; R Krumlauf; M Gassmann
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain.

Authors:  E S Anton; H T Ghashghaei; Janet L Weber; Corey McCann; Tobias M Fischer; Isla D Cheung; Martin Gassmann; Albee Messing; Rudiger Klein; Markus H Schwab; K C Kent Lloyd; Cary Lai
Journal:  Nat Neurosci       Date:  2004-11-07       Impact factor: 24.884

3.  Molecular karyotyping: array CGH quality criteria for constitutional genetic diagnosis.

Authors:  Joris R Vermeesch; Cindy Melotte; Guy Froyen; Steven Van Vooren; Binita Dutta; Nicole Maas; Stefan Vermeulen; Björn Menten; Frank Speleman; Bart De Moor; Paul Van Hummelen; Peter Marynen; Jean-Pierre Fryns; Koen Devriendt
Journal:  J Histochem Cytochem       Date:  2005-03       Impact factor: 2.479

4.  Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes.

Authors:  Hilde Van Esch; Anna Jansen; Marijke Bauters; Guy Froyen; Jean-Pierre Fryns
Journal:  Am J Med Genet A       Date:  2007-02-15       Impact factor: 2.802

Review 5.  The neuregulin-I/ErbB signaling system in development and disease.

Authors:  Stefan Britsch
Journal:  Adv Anat Embryol Cell Biol       Date:  2007       Impact factor: 1.231

6.  A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome).

Authors:  Mitsuhiro Kato; Shinji Saitoh; Atsushi Kamei; Hideaki Shiraishi; Yuki Ueda; Manami Akasaka; Jun Tohyama; Noriyuki Akasaka; Kiyoshi Hayasaka
Journal:  Am J Hum Genet       Date:  2007-06-11       Impact factor: 11.025

7.  Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons.

Authors:  Karine Poirier; Hilde Van Esch; Gaëlle Friocourt; Yoann Saillour; Nadia Bahi; Stéphanie Backer; Evelyne Souil; Laetitia Castelnau-Ptakhine; Cherif Beldjord; Fiona Francis; Thierry Bienvenu; Jamel Chelly
Journal:  Brain Res Mol Brain Res       Date:  2004-03-17

8.  Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus.

Authors:  N Mechawar; B Lacoste; W-F Yu; L K Srivastava; R Quirion
Journal:  Neuroscience       Date:  2007-07-16       Impact factor: 3.590

9.  The three stages of epilepsy in patients with CDKL5 mutations.

Authors:  Nadia Bahi-Buisson; Anna Kaminska; Nathalie Boddaert; Marlène Rio; Alexandra Afenjar; Marion Gérard; Fabienne Giuliano; Jacques Motte; Delphine Héron; Marie Ange N'guyen Morel; Perrine Plouin; Christian Richelme; Vincent des Portes; Olivier Dulac; Christophe Philippe; Catherine Chiron; Rima Nabbout; Thierry Bienvenu
Journal:  Epilepsia       Date:  2008-02-07       Impact factor: 5.864

10.  Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia.

Authors:  Amanda J Law; Joel E Kleinman; Daniel R Weinberger; Cynthia Shannon Weickert
Journal:  Hum Mol Genet       Date:  2006-12-12       Impact factor: 6.150

View more
  17 in total

1.  ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.

Authors:  Ville Veikkolainen; Florence Naillat; Antti Railo; Lijun Chi; Aki Manninen; Peter Hohenstein; Nick Hastie; Seppo Vainio; Klaus Elenius
Journal:  J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 10.121

2.  Specific regulation of NRG1 isoform expression by neuronal activity.

Authors:  Xihui Liu; Ryan Bates; Dong-Min Yin; Chengyong Shen; Fay Wang; Nan Su; Sergei A Kirov; Yuling Luo; Jian-Zhi Wang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

3.  Neuregulin 1-induced AKT and ERK phosphorylation in patients with fragile X syndrome (FXS) and intellectual disability associated with obstetric complications.

Authors:  Tamás Kovács; Boglárka Bánsági; Oguz Kelemen; Szabolcs Kéri
Journal:  J Mol Neurosci       Date:  2014-02-23       Impact factor: 3.444

Review 4.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

Review 5.  Shedding Light on Chandelier Cell Development, Connectivity, and Contribution to Neural Disorders.

Authors:  Nicholas B Gallo; Anirban Paul; Linda Van Aelst
Journal:  Trends Neurosci       Date:  2020-06-18       Impact factor: 13.837

6.  Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.

Authors:  Guo-He Tan; Yuan-Yuan Liu; Xiao-Ling Hu; Dong-Min Yin; Lin Mei; Zhi-Qi Xiong
Journal:  Nat Neurosci       Date:  2011-12-11       Impact factor: 24.884

7.  Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function.

Authors:  Alex R Paciorkowski; Liu Lin Thio; Jill A Rosenfeld; Marzena Gajecka; Christina A Gurnett; Shashikant Kulkarni; Wendy K Chung; Eric D Marsh; Mattia Gentile; James D Reggin; James W Wheless; Sandhya Balasubramanian; Ravinesh Kumar; Susan L Christian; Carla Marini; Renzo Guerrini; Natalia Maltsev; Lisa G Shaffer; William B Dobyns
Journal:  Eur J Hum Genet       Date:  2011-06-22       Impact factor: 4.246

8.  Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness.

Authors:  Isabelle Perrault; Fadi F Hamdan; Marlène Rio; José-Mario Capo-Chichi; Nathalie Boddaert; Jean-Claude Décarie; Bruno Maranda; Rima Nabbout; Michel Sylvain; Anne Lortie; Philippe P Roux; Elsa Rossignol; Xavier Gérard; Giulia Barcia; Patrick Berquin; Arnold Munnich; Guy A Rouleau; Josseline Kaplan; Jean-Michel Rozet; Jacques L Michaud
Journal:  Am J Hum Genet       Date:  2014-05-08       Impact factor: 11.025

Review 9.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  Molecular cytogenetic characterisation of a mosaic add(12)(p13.3) with an inv dup(3)(q26.31 --> qter) detected in an autistic boy.

Authors:  Isabel M Carreira; Joana B Melo; Carlos Rodrigues; Liesbeth Backx; Joris Vermeesch; Anja Weise; Nadezda Kosyakova; Guiomar Oliveira; Eunice Matoso
Journal:  Mol Cytogenet       Date:  2009-08-04       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.